Thienopyrimidinedione derivatives as TRPA1 modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9474758
APP PUB NO 20150150876A1
SERIAL NO

14620721

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is related to novel thienopyrimidinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLENMARK PHARMACEUTICALS S A2300 LA CHAUX-DE-FONDS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Khairatkar-Joshi, Neelima Thane, IN 58 205
Kumar, Sukeerthi Navi Mumbai, IN 13 82
Margal, Sanjay Navi Mumbai, IN 5 33
Mukhopadhyay, Indranil Navi Mumbai, IN 13 90
Thomas, Abraham Navi Mumbai, IN 50 202
Waghmare, Nayan Taterao Dist-Pune, IN 3 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 25, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00